Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 12 Aug 2026 for Bicara Therapeutics Inc., €33k.
Filing timeline
BuySaleClaire Mazumdar
Insider track record
Disclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Claire Mazumdar: trading record in brief
This profile gathers the share dealings of Claire Mazumdar in Bicara Therapeutics Inc. In total, 33 filings cover trades dated from 13 October 2025 to 10 August 2026.
No open-market purchase appears, only 15 sales worth €3.2M. The rest of the record consists of 18 option exercises. 2026 to date brings no purchases and 11 sales.
The newest entry dates from 12 August 2026: an option exercise of €33k, in Bicara Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Claire Mazumdar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
10,000 shares@ US$3.7898Common StockSEC:0001470831-26-000813:0
10,000 shares@ US$27.975Common StockSEC:0001470831-26-000813:1
10,000 shares@ US$3.78980.0020% mcap2.2% of flowCommon StockSEC:0001470831-26-000714:0
9,972 shares@ US$28.41630.015% mcap16.3% of flowCommon StockSEC:0001470831-26-000714:1
28 shares@ US$29.680.0000% mcap0.0% of flowCommon StockSEC:0001470831-26-000714:2
8,226 shares@ US$4.43690.0018% mcap7.1% of flowCommon StockSEC:0001628280-26-026089:0
7,454 shares@ US$3.78980.0014% mcap5.5% of flowCommon StockSEC:0001628280-26-026089:1
7,080 shares@ US$5.45370.0019% mcap7.5% of flowCommon StockSEC:0001628280-26-026089:2
15,000 shares@ US$3.78980.0029% mcap11.1% of flowCommon StockSEC:0001628280-26-026089:3
15,000 shares@ US$23.60970.018% mcap68.9% of flowCommon StockSEC:0001628280-26-026089:4
6,499 shares@ US$3.78984.7% of flowCommon StockSEC:0001628280-26-020236:0
36,766 shares@ US$3.789812.4% of flowCommon StockSEC:0001628280-26-016874:0
2,631 shares@ US$3.78980.9% of flowCommon StockSEC:0001628280-26-015778:0
29,500 shares@ US$5.453716.2% of flowCommon StockSEC:0002034671-25-000012:0
41,163 shares@ US$3.789819.1% of flowCommon StockSEC:0002034671-25-000009:0
24,103 shares@ US$3.789813.6% of flowCommon StockSEC:0002034671-25-000006:0
11,445 shares@ US$3.78986.5% of flowCommon StockSEC:0002034671-25-000003:0
17 of 17 declarations
